Clinical Education
Cardio-oncology as its own discipline: what a global training survey shows
Read more: Cardio-oncology as its own discipline: what a global training survey showsCardio-oncology lives at the juntion between two fast-moving fields. Cancer treatment keeps improving, patients live longer, and more of those patients carry cardiovascular risk that has to be managed alongside their oncology care. That much is not…
Insights from ESC Cardio-Oncology Conference
Read more: Insights from ESC Cardio-Oncology ConferenceI recently attended ESC Cardio-Oncology 2026 in Vienna. Alongside other major international gatherings like Global Cardio-Oncology Summit, the ESC Cardio-Oncology Conference remains a vital forum for experts at the intersection of cardiology and cancer care. This trip wasn’t just…
Exercise during and after cancer treatment: an evidence-based guide
Read more: Exercise during and after cancer treatment: an evidence-based guideQuick answer Structured exercise during and after cancer treatment is safe for most patients, protects the heart against the long-term cardiovascular consequences of cancer therapy, and in stage III or high-risk stage II colon cancer now has…
Predict Better. Protect Better. Now Let’s Build Cardio-Oncology Service Better, Together.
Read more: Predict Better. Protect Better. Now Let’s Build Cardio-Oncology Service Better, Together.A new state-of-the-art review on risk prediction in cardio-oncology, and an invitation to help build the tools this field still needs.
When “Moderate” Isn’t Moderate: A New Way to Assess Risk in Aortic Stenosis
Read more: When “Moderate” Isn’t Moderate: A New Way to Assess Risk in Aortic StenosisThe moderate aortic stenosis risk score is a new clinical tool designed to predict who is truly at risk of cardiac death or heart failure hospitalisation — and who is likely to do well. If you have…
Cardio-Oncology Fellowship Training: Why a Full Year Matters
Read more: Cardio-Oncology Fellowship Training: Why a Full Year MattersDr Jonathan Sen explains why a full year of dedicated cardio-oncology fellowship, with integrated imaging and research at UHN Toronto, shapes better cardiac care for cancer patients in Brisbane.
Troponin Up on Immune Checkpoint Inhibitor: Panic, Pause, or Press On?
Read more: Troponin Up on Immune Checkpoint Inhibitor: Panic, Pause, or Press On?For clinicians on the front line, including GPs, emergency physicians, and oncologists, the question is what to do when a troponin comes back elevated in someone receiving immunotherapy. Not every troponin rise means myocarditis. But missing the…
The Intersection of Cancer and Heart Disease
Read more: The Intersection of Cancer and Heart DiseaseThanks to current advances in chemotherapy, immunotherapy, targeted therapies, and radiation techniques, five-year survival rates for a range of malignancies have improved dramatically—from 50% in the late 1980s to 72% in 2017–2021 (Australian Institute of Health and…
